TEPANIL Drug Patent Profile
✉ Email this page to a colleague
When do Tepanil patents expire, and what generic alternatives are available?
Tepanil is a drug marketed by 3M and is included in two NDAs.
The generic ingredient in TEPANIL is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tepanil
A generic version of TEPANIL was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
Summary for TEPANIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 19 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TEPANIL at DailyMed |
US Patents and Regulatory Information for TEPANIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3m | TEPANIL | diethylpropion hydrochloride | TABLET;ORAL | 011673-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
3m | TEPANIL TEN-TAB | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 017956-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |